The Indian pharmaceutical market (IPM) saw a robust growth of 9.5% in January with all major therapy areas recording double-digit growth. According to market research firm Pharmarack, a majority of the top 10 therapy areas, including cardiac, anti-infectives, and gastrointestinal, showed double-digit value growth. Respiratory, pain/analgesics, urology, antineoplastics, and stomatologicals also saw higher unit growth.
